Banks to allow NIS 1,000 credit excess

Banks will be permitted to honor checks and account debits, even if the current account is being exceeded moderately, according to a new adjustment to the credit regulation law by the Supervisor of Banks.

By SHARON WROBEL
December 18, 2006 07:11

 
X

Dear Reader,
As you can imagine, more people are reading The Jerusalem Post than ever before. Nevertheless, traditional business models are no longer sustainable and high-quality publications, like ours, are being forced to look for new ways to keep going. Unlike many other news organizations, we have not put up a paywall. We want to keep our journalism open and accessible and be able to keep providing you with news and analyses from the frontlines of Israel, the Middle East and the Jewish World.

As one of our loyal readers, we ask you to be our partner.

For $5 a month you will receive access to the following:

  • A user experience almost completely free of ads
  • Access to our Premium Section
  • Content from the award-winning Jerusalem Report and our monthly magazine to learn Hebrew - Ivrit
  • A brand new ePaper featuring the daily newspaper as it appears in print in Israel

Help us grow and continue telling Israel’s story to the world.

Thank you,

Ronit Hasin-Hochman, CEO, Jerusalem Post Group
Yaakov Katz, Editor-in-Chief

UPGRADE YOUR JPOST EXPERIENCE FOR 5$ PER MONTH Show me later

Banks will be permitted to honor checks and account debits, even if the current account is being exceeded moderately, according to a new adjustment to the credit regulation law by the Supervisor of Banks. The leeway of credit excess, limited to NIS 1,000, is being introduced in order to help customers and banks adjust to and implement the new credit regulations that went into effect on July 1 this year. In addition, the banks received a six-month extension to the deadline by which all credit frameworks of current accounts need to be arranged - that is from the original January 1, 2007 deadline to July 1 2007.

Join Jerusalem Post Premium Plus now for just $5 and upgrade your experience with an ads-free website and exclusive content. Click here>>

Related Content

The Teva Pharmaceutical Industries
April 30, 2015
Teva doubles down on Mylan, despite rejection

By GLOBES, NIV ELIS